FDA Approved: NILOTINIB — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approval of an Original Application for nilotinib by Cipla USA Inc., a generic version of Tasigna for treatment of Philadelphia chromosome-positive chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

ORIG AP for NILOTINIB (NILOTINIB)